Now that's the type of research we can all be glad to see - Jan 29 publication from Beijing researchers. Long humanity, short 2019-nCoV https://www.biorxiv.org/content/10.1101/2020.01.29.924100v1.full.pdf+html …pic.twitter.com/P7p6a3l0Me
U tweetove putem weba ili aplikacija drugih proizvođača možete dodati podatke o lokaciji, kao što su grad ili točna lokacija. Povijest lokacija tweetova uvijek možete izbrisati. Saznajte više
In a similar vein, this paper from Jan 28 looked at antibodies that worked with SARS. Unfortunately the most potent ones didn't bind to 2019-nCoV, but they found 1 that did (phew). https://www.biorxiv.org/content/10.1101/2020.01.28.923011v1.article-info …pic.twitter.com/neuEk9LSnf
Jan 29 - Chinese researchers identify 4 (from 8,000) clinical drugs that can bind to the main replication enzyme (protease) of SARS-CoV. It has 96.1% similarity to 2019-nCoV. Meaning these 4 candidates can be further screened to see if they can inhibit the virus spread in people.pic.twitter.com/djXT67uwFx
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.